跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Sitazit 25 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Sitazit 25
Approved
STANDARD
Sitazit 25
Hetero Labs Limited, Unit V
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
c2aa7746151db9f2
Company
Hetero Labs Limited, Unit V
Type
Standard
Approval Details
Approval Id
c2aa7746151db9f2
Drug Approval Philippines Name
Sitazit 25
Product Name
Sitazit 25
Registration Number
DR-XY48547
Brand Name
Sitazit 25
Generic Name
Sitagliptin (As Hydrochloride)
Dosage Form
Film-Coated Tablet
Dosage Strength
25 mg
Manufacturer
Hetero Labs Limited, Unit V
Importer
Camber Pharmaceuticals, Inc.
Distributor
Camber Pharmaceuticals, Inc.
Importer Detail Path
/organization/camber-pharmaceuticals-inc
Distributor Detail Path
/organization/camber-pharmaceuticals-inc
Issuance Date
29 December 2022
Expiry Date
29 December 2027
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
c2aa7746151db9f2
Type
Standard
Back to Philippines FDA Approvals